Ezgi Hacihasanoglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ezgi Hacihasanoglu has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alperen Msc Tuncer
Department of Genetics and Bioengineering, Faculty of Engineering, Yeditepe University, Istanbul, Turkey
1 shared publication - Ayşe Gökçen Sade
Sultan Abdulhamid Han Educational and Research Hospital, Türkiye
1 shared publication - Begüm Çalım Gürbüz
Pathology Department, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey
1 shared publication - Cansu Benli Işık
Istanbul Haseki Eğitim ve Araştırma Hastanesi
1 shared publication Cemile Özdemir
1 shared publication- Dilek Yilmaz
Department of Pathology, Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital, University of Health Sciences, İstanbul, Turkiye
1 shared publication
Latest Publications
- Open Access
- 2 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (48) , e32009
Production of parathyroid-like cells from thyroid stem cells in co-culture environment
Background: Parathyroid-like cells were aimed to be developed using cells isolated from thyroid since their embryological origins are the same. Method: Activin A and sonic hedgehog (Shh) are the proteins used in differentiation (dif) medium. Parathyroid and thyroid cells were cultured in a 3-dimensional environment and divided into five groups: thyroid standard (st) medium, thyroid dif medium, parathyroid st medium, thyroid-parathyroid co-culture st medium, and thyroid-parathyroid co-culture dif medium. Throughout 28 days of incubation, groups were investigated by carrying out the live dead assay, confocal microscopy, real-time PCR, immunohistochemistry and biochemical assays. Results: Thyroid-parathyroid co-culture cells grown in dif medium exhibited upregulated expressions of parathormone (PTH) (5.1-fold), PTH1R (3.6-fold), calcium sensing receptor (CaSR) (8.8-fold), and loss of thyroid-specific thyroid transcription factor 1 (TTF1) expression when compared to the thyroid st medium group. PTH secretion decreased by 35% in the parathyroid st medium group and 99.9% in the thyroid-parathyroid co-culture st medium group but decreased only 3.5% in the thyroid-parathyroid co-culture dif medium group on day 28. Conclusion: Using Activin A and Shh proteins, thyroid stem/progenitor cells were differentiated to parathyroid-like cells successfully in a co-culture environment. A potentially effective novel method for cell differenatiation is co-culture of cells having the same embryological origin.
- 2 December 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (48) , e32009
Open AccessProduction of parathyroid-like cells from thyroid stem cells in co-culture environment
Background: Parathyroid-like cells were aimed to be developed using cells isolated from thyroid since their embryological origins are the same. Method: Activin A and sonic hedgehog (Shh) are the proteins used in differentiation (dif) medium. Parathyroid and thyroid cells were cultured in a 3-dimensional environment and divided into five groups: thyroid standard (st) medium, thyroid dif medium, parathyroid st medium, thyroid-parathyroid co-culture st medium, and thyroid-parathyroid co-culture dif medium. Throughout 28 days of incubation, groups were investigated by carrying out the live dead assay, confocal microscopy, real-time PCR, immunohistochemistry and biochemical assays. Results: Thyroid-parathyroid co-culture cells grown in dif medium exhibited upregulated expressions of parathormone (PTH) (5.1-fold), PTH1R (3.6-fold), calcium sensing receptor (CaSR) (8.8-fold), and loss of thyroid-specific thyroid transcription factor 1 (TTF1) expression when compared to the thyroid st medium group. PTH secretion decreased by 35% in the parathyroid st medium group and 99.9% in the thyroid-parathyroid co-culture st medium group but decreased only 3.5% in the thyroid-parathyroid co-culture dif medium group on day 28. Conclusion: Using Activin A and Shh proteins, thyroid stem/progenitor cells were differentiated to parathyroid-like cells successfully in a co-culture environment. A potentially effective novel method for cell differenatiation is co-culture of cells having the same embryological origin.
- Open Access
- 15 October 2022
- Published by Academician Publishing
Deri Eki Tümörleri
Deri eki tümörleri nadir görülen ve birbirine benzeyen tümörler olduğundan tanılarının konması ve ayırıcı tanılarının yapılması genellikle zordur. Bu konuda ulaşılabilen Türkçe kaynakların da sınırlı olması nedeniyle bu kitabın oluşturulma sürecini başlattık. Amacımız , genç meslektaşlarımıza yönelik güncel bir kaynak oluşturmaya katkıda bulunmaktı. Kitabın oluşumunda tüm yazarlarımız ile birlikte uzun ve yorucu bir süreçte elimizden gelen çabayı göstermiş olmamıza rağmen; varsa eksikliklerimiz için affınıza sığınıyoruz. Pilar Kılıf Akantomu ve Dilate Por Nurtaç ASA SARIKAŞ Prolifere Pilar Tümör Hazal TAŞ SOLAK Trikilemmom Emel DAŞGIN BİTLİS Trikofoliküloma Meryem YÜVRÜK Trikoepitelyoma Tevhide Bilgen ÖZCAN Pilomatriksoma Fatma Gülçiçek AYRANCI Trikoblastom Begüm ÇALIM GÜRBÜZ Tuçe SÖYLEMEZ AKKURT Trikilemmal Karsinom Dilek YILMAZ Sebase Hiperplazi Cansu BENLİ IŞIK Sebase Adenom Cemile ÖZDEMİR Sebaseoma Ezgi HACIHASANOĞLU Nevüs Sebaseus Vildan ELİBOL Sebasöz Karsinom Begüm ÇALIM GÜRBÜZ Hidrokistoma ve Kistadenom Gamze KULDUK Özben YALÇIN Silindirom Rabia Burçin GİRGİN Spiradenom Nilsen YILDIRIM ERDOĞAN Spiradenomdan Kaynaklanan Malign Neoplazi/Malign Spiradenom Nilsen YILDIRIM ERDOĞAN Siringom Rabia Burçin GİRGİN Siringofibroadenom Rabia Burçin GİRGİN Siringokistadenoma Papilliferum Nilüfer GÜRSAN Kondroid Siringom Meryem YÜVRÜK Hidradenom Gamze KULDUK Tübüler Apokrin Adenom Selma ERDOĞAN DÜZCÜ Papiller Ekrin Adenom Selma ERDOĞAN DÜZCÜ Poroma Özben YALÇIN Dermal Duktus Tümörü Zeynep Betül ERDEM Hidradenoma Papilliferum Nilüfer GÜRSAN Mikrokistik Adneksiyal Karsinom Ayşe Gökçen SADE Primer Kutanöz Adenoid Kistik Karsinom Zeynep TOSUNER Porokarsinom Zeynep TOSUNER Kutanöz Apokrin Karsinom Vildan ELİBOL Primer Kutanöz Müsinöz Karsinom Zeynep TOSUNER Emel DİKİCİOĞLU ÇETİN Hidradenokarsinom Melin ÖZGÜN GEÇER Digital Papiller Adenokarsinom Melin ÖZGÜN GEÇER
- 15 October 2022
- Published by Academician Publishing
Open AccessDeri Eki Tümörleri
Deri eki tümörleri nadir görülen ve birbirine benzeyen tümörler olduğundan tanılarının konması ve ayırıcı tanılarının yapılması genellikle zordur. Bu konuda ulaşılabilen Türkçe kaynakların da sınırlı olması nedeniyle bu kitabın oluşturulma sürecini başlattık. Amacımız , genç meslektaşlarımıza yönelik güncel bir kaynak oluşturmaya katkıda bulunmaktı. Kitabın oluşumunda tüm yazarlarımız ile birlikte uzun ve yorucu bir süreçte elimizden gelen çabayı göstermiş olmamıza rağmen; varsa eksikliklerimiz için affınıza sığınıyoruz. Pilar Kılıf Akantomu ve Dilate Por Nurtaç ASA SARIKAŞ Prolifere Pilar Tümör Hazal TAŞ SOLAK Trikilemmom Emel DAŞGIN BİTLİS Trikofoliküloma Meryem YÜVRÜK Trikoepitelyoma Tevhide Bilgen ÖZCAN Pilomatriksoma Fatma Gülçiçek AYRANCI Trikoblastom Begüm ÇALIM GÜRBÜZ Tuçe SÖYLEMEZ AKKURT Trikilemmal Karsinom Dilek YILMAZ Sebase Hiperplazi Cansu BENLİ IŞIK Sebase Adenom Cemile ÖZDEMİR Sebaseoma Ezgi HACIHASANOĞLU Nevüs Sebaseus Vildan ELİBOL Sebasöz Karsinom Begüm ÇALIM GÜRBÜZ Hidrokistoma ve Kistadenom Gamze KULDUK Özben YALÇIN Silindirom Rabia Burçin GİRGİN Spiradenom Nilsen YILDIRIM ERDOĞAN Spiradenomdan Kaynaklanan Malign Neoplazi/Malign Spiradenom Nilsen YILDIRIM ERDOĞAN Siringom Rabia Burçin GİRGİN Siringofibroadenom Rabia Burçin GİRGİN Siringokistadenoma Papilliferum Nilüfer GÜRSAN Kondroid Siringom Meryem YÜVRÜK Hidradenom Gamze KULDUK Tübüler Apokrin Adenom Selma ERDOĞAN DÜZCÜ Papiller Ekrin Adenom Selma ERDOĞAN DÜZCÜ Poroma Özben YALÇIN Dermal Duktus Tümörü Zeynep Betül ERDEM Hidradenoma Papilliferum Nilüfer GÜRSAN Mikrokistik Adneksiyal Karsinom Ayşe Gökçen SADE Primer Kutanöz Adenoid Kistik Karsinom Zeynep TOSUNER Porokarsinom Zeynep TOSUNER Kutanöz Apokrin Karsinom Vildan ELİBOL Primer Kutanöz Müsinöz Karsinom Zeynep TOSUNER Emel DİKİCİOĞLU ÇETİN Hidradenokarsinom Melin ÖZGÜN GEÇER Digital Papiller Adenokarsinom Melin ÖZGÜN GEÇER
- Open Access
- 1 January 2021
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 37 (1) , 26-31
Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas
Objective: Micropapillary urothelial carcinoma is an aggressive variant of urothelial carcinoma. Evidence suggests that the relationship between the tumor and inflammatory cells is important in tumor progression and the treatment response. We evaluated the stromal lymphoid response in micropapillary urothelial carcinomas and compared it with conventional urothelial carcinomas. Material and Method: Among bladder transurethral resection materials diagnosed as 'invasive urothelial carcinoma' between January 2010-March 2017, cases with at least 5% micropapillary urothdial carcinoma were evaluated for age, gender, grade, stage, micropapillary urothelial carcinoma percentage, presence/percentage of accompanying conventional urothelial carcinoma/urothelial carcinoma variants, in situ urothelial carcinoma/micropapillary urothelial carcinoma, lymphovascular invasion, necrosis, and stromal lymphoid response. Stromal lymphoid response was scored as 0-1-2-3. All parameters were evaluated in 50 pure conventional urothelial carcinomas. Results: Among 47 micropapillary urothelial carcinomas, 41 were male. The mean age was 69 years. pT1/pT2 was 23/24. Six cases were pure MPUC. Lymphovascular invasion was present in 8, necrosis in 9 cases. Stromal lymphoid response was present and scored as 1-2-3 in 32 micropapillary urothelial carcinomas (68.1%) and 48 conventional urothelial carcinomas (96%). Micropapillary urothelial carcinomas had significantly higher lymphovascular invasion and pT2 rates and lower stromal lymphoid response. Conclusion: Low stromal lymphoid response in micropapillary urothelial carcinomas can be responsible for the poor clinical outcome and impaired response to treatment of these tumors. This is the first study in the English literature to demonstrate a lower stromal lymphoid response rate in micropapillary urothelial carcinomas compared to conventional urothelial carcinomas.
- 1 January 2021
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 37 (1) , 26-31
Open AccessStromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas
Objective: Micropapillary urothelial carcinoma is an aggressive variant of urothelial carcinoma. Evidence suggests that the relationship between the tumor and inflammatory cells is important in tumor progression and the treatment response. We evaluated the stromal lymphoid response in micropapillary urothelial carcinomas and compared it with conventional urothelial carcinomas. Material and Method: Among bladder transurethral resection materials diagnosed as 'invasive urothelial carcinoma' between January 2010-March 2017, cases with at least 5% micropapillary urothdial carcinoma were evaluated for age, gender, grade, stage, micropapillary urothelial carcinoma percentage, presence/percentage of accompanying conventional urothelial carcinoma/urothelial carcinoma variants, in situ urothelial carcinoma/micropapillary urothelial carcinoma, lymphovascular invasion, necrosis, and stromal lymphoid response. Stromal lymphoid response was scored as 0-1-2-3. All parameters were evaluated in 50 pure conventional urothelial carcinomas. Results: Among 47 micropapillary urothelial carcinomas, 41 were male. The mean age was 69 years. pT1/pT2 was 23/24. Six cases were pure MPUC. Lymphovascular invasion was present in 8, necrosis in 9 cases. Stromal lymphoid response was present and scored as 1-2-3 in 32 micropapillary urothelial carcinomas (68.1%) and 48 conventional urothelial carcinomas (96%). Micropapillary urothelial carcinomas had significantly higher lymphovascular invasion and pT2 rates and lower stromal lymphoid response. Conclusion: Low stromal lymphoid response in micropapillary urothelial carcinomas can be responsible for the poor clinical outcome and impaired response to treatment of these tumors. This is the first study in the English literature to demonstrate a lower stromal lymphoid response rate in micropapillary urothelial carcinomas compared to conventional urothelial carcinomas.